In the case of CREBRF, we hypothesize that maternal-fetal co-occurrence of the A allele synergistically provides greater protection against GDM compared to maternal genetics alone, leading to improved anthropometric outcomes in children via fetal programming. The gene discussed is CREBRF; the disease is gestational diabetes.